Status:
COMPLETED
Assessment of Left and Right Ventricular Function in Patients With Ebstein Anomaly With Different Echocardiographic Methods
Lead Sponsor:
Angela Oxenius
Collaborating Sponsors:
University Hospital, Zürich
Conditions:
Ebstein Anomaly
Eligibility:
All Genders
11-80 years
Brief Summary
Ebstein anomaly is a rare congenital heart disease. It encompasses abnormalities of the tricuspid valve, the right atrium and the right ventricle (RV). Currently, cardiac magnetic resonance imaging (...
Eligibility Criteria
Inclusion
- Ebstein anomaly
- male and female 11 years to 80 years of age
- Unoperated or operated on the heart, including 1 1/2 chamber palliation
- Wolff-Parkinson-White Syndrome
Exclusion
- moderate or severe mitral valve insufficiency, moderate or severe aortic insufficiency, moderate or severe aortic stenosis
- Univentricular palliation (Fontan)
- St.n. myectomy of the left ventricle
- Concomitant L-transposition of the great arteries
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01907971
Start Date
August 1 2013
End Date
January 1 2015
Last Update
May 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Childrens Hospital
Zurich, Canton of Zurich, Switzerland, 8032